Straumann Holding AG (STMN.SW) Stock

STMN.SW logo

Straumann Holding AG

STMN.SWSwitzerland
Healthcare

Company profile

Straumann Holding reported revenue of 2.61 billion CHF for fiscal year 2025, up 4.1% from fiscal year 2024, and net income of 355.92 million CHF. That is a net profit margin of 13.7% for fiscal year 2025. Its largest business segment, Operations, brought in 32% of segment revenue in fiscal year 2025; Other was the largest region with 36%. Our analysis of its filings shows revenue growing from 2.28 billion CHF in fiscal year 2023 to 2.61 billion CHF in fiscal year 2025, 7.0% a year on average. Straumann Holding reports about 11,582 full-time employees.

What stands out

  • Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.

Figures from company filings; latest fiscal year ended December 31, 2025.

About Straumann Holding AG

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Largest shareholders

  • H. C. Straumann15.46 %15.46%
  • Rudolf Maag10.2 %10.20%
  • Gabriella Straumann3 %3.00%
  • Comgest Asset Management International Ltd.0.46%
  • Mirabaud Asset Management (Suisse) SA0.27%

Share of the company, as of September 25, 2026

Leadership

  • Guillaume Daniellot — CEO, Interim Head of Dental Service Organizations & Member of Executive Management Board, 55
  • Isabelle Wege — CFO & Member of Executive Management Board, 40
  • Sébastien Roche — Chief Operations & Supply Chain Officer and Member of Executive Management Board, 53
  • Thomas Friese — Chief Technology & Information Officer and Member of Executive Management Board, 50
  • Alexei Costa — Executive VP of Latin America, President Neodent & Member of Executive Management Board, 47

How much revenue does Straumann Holding make?

Straumann Holding reported 2.61 billion CHF in revenue for fiscal year 2025, up 4.1% from 2.50 billion CHF in fiscal year 2024.

What is Straumann Holding's largest business segment?

Operations, with 1.34 billion CHF or 32% of segment revenue in fiscal year 2025. Next: Sales Europe, Middle East and Africa (27%) and Sales North America (18%).

Where does Straumann Holding make most of its revenue?

Other: 36% of revenue by region in fiscal year 2025, followed by United States of America (24%).

What companies are similar to Straumann Holding?

Listed companies of a similar size in the same industry (additional specific healthcare equipment) include Sonova Holding AG (SOON.SW), Coltene Holding AG (CLTN.SW).

How has Straumann Holding's revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, 2.02 billion CHF; FY2022, 2.32 billion CHF; FY2023, 2.28 billion CHF; FY2024, 2.50 billion CHF; FY2025, 2.61 billion CHF.

Company Information

SectorHealthcare
IndustryAdditional Specific Healthcare Equipment
Employees11,582
FoundedJan 1, 1954
IPO DateDec 19, 2014
IPO StatusPublic
HeadquartersBasel, Switzerland
FoundersFritz Straumann
ExchangeSwiss
TimezoneEurope/Zurich (CET)

Contact & Links

Address
Peter Merian-Weg 12, Basel, 4002
Phone
41 61 965 11 11
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Straumann Holding AG (STMN.SW)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/STMN.SW

LinkedInLinkedInXXYouTubeYouTube